Literature DB >> 12502866

Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity.

Pramod P Naranatt1, Shaw M Akula, Christopher A Zien, Harinivas H Krishnan, Bala Chandran.   

Abstract

Human herpesvirus 8 (HHV-8) is implicated in the pathogenesis of Kaposi's sarcoma. HHV-8 envelope glycoprotein B (gB) possesses the RGD motif known to interact with integrin molecules, and HHV-8 infectivity was inhibited by RGD peptides, by antibodies against alpha3 and beta1 integrins, and by soluble alpha3beta1 integrin (S. M. Akula, N. P. Pramod, F.-Z. Wang, and B. Chandran, Cell 108:407-419, 2002). Anti-gB antibodies immunoprecipitated the virus alpha3 and beta1 complexes, and virus-binding studies suggest a role for alpha3beta1 in HHV-8 entry. HHV-8 infection induced the integrin-mediated activation of focal adhesion kinase (FAK), implicating a role for integrin and the associated signaling pathways in HHV-8 entry into the target cells. Immediately after infection, target cells exhibited morphological changes and cytoskeletal rearrangements, suggesting the induction of signal pathways. As early as 5 min postinfection, HHV-8 activated the MEK-ERK1/2 pathway. The focal adhesion components phosphatidylinositol 3-kinase (PI 3-kinase) and protein kinase C-zeta (PKC-zeta) were recruited as upstream mediators of the HHV-8-induced ERK pathway. Anti-HHV-8 gB-neutralizing antibodies and soluble alpha3beta1 integrin inhibited the virus-induced signaling pathways. Early kinetics of the cellular signaling pathway and its activation by UV-inactivated HHV-8 suggest a role for virus binding and/or entry but not viral gene expression in this induction. Studies with human alpha3 integrin-transfected Chinese hamster ovary cells and FAK-negative mouse DU3 cells suggest that the alpha3beta1 integrin and FAK play roles in the HHV-8 mediated signal induction. Inhibitors specific for PI 3-kinase, PKC-zeta, MEK, and ERK significantly reduced the virus infectivity without affecting virus binding to the target cells. Examination of viral DNA entry suggests a role for PI 3-kinase in HHV-8 entry into the target cells and a role for PKC-zeta, MEK, and ERK at a post-viral entry stage of infection. These findings implicate a critical role for integrin-associated mitogenic signaling in HHV-8's infection of target cells and suggest that, by orchestrating the signal cascade, HHV-8 may create an appropriate intracellular environment to facilitate the infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502866      PMCID: PMC140802          DOI: 10.1128/jvi.77.2.1524-1539.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

Review 1.  Protein kinase C and the cytoskeleton.

Authors:  C Keenan; D Kelleher
Journal:  Cell Signal       Date:  1998-04       Impact factor: 4.315

2.  Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.

Authors:  D Weissman; R L Rabin; J Arthos; A Rubbert; M Dybul; R Swofford; S Venkatesan; J M Farber; A S Fauci
Journal:  Nature       Date:  1997-10-30       Impact factor: 49.962

Review 3.  Rho GTPases and the actin cytoskeleton.

Authors:  A Hall
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

4.  Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells.

Authors:  R Renne; D Blackbourn; D Whitby; J Levy; D Ganem
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1).

Authors:  R Sarid; O Flore; R A Bohenzky; Y Chang; P S Moore
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes.

Authors:  D C Schönwasser; R M Marais; C J Marshall; P J Parker
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

7.  Integrin-mediated activation of MEK and mitogen-activated protein kinase is independent of Ras [corrected].

Authors:  Q Chen; T H Lin; C J Der; R L Juliano
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

8.  Identification of a novel inhibitor of mitogen-activated protein kinase kinase.

Authors:  M F Favata; K Y Horiuchi; E J Manos; A J Daulerio; D A Stradley; W S Feeser; D E Van Dyk; W J Pitts; R A Earl; F Hobbs; R A Copeland; R L Magolda; P A Scherle; J M Trzaskos
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

9.  Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice.

Authors:  D Ilić; Y Furuta; S Kanazawa; N Takeda; K Sobue; N Nakatsuji; S Nomura; J Fujimoto; M Okada; T Yamamoto
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

10.  Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5.

Authors:  C B Davis; I Dikic; D Unutmaz; C M Hill; J Arthos; M A Siani; D A Thompson; J Schlessinger; D R Littman
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

View more
  113 in total

1.  c-Cbl-mediated selective virus-receptor translocations into lipid rafts regulate productive Kaposi's sarcoma-associated herpesvirus infection in endothelial cells.

Authors:  Sayan Chakraborty; Mohanan ValiyaVeettil; Sathish Sadagopan; Nitika Paudel; Bala Chandran
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Postinternalization inhibition of adenovirus gene expression and infectious virus production in human T-cell lines.

Authors:  Adrienne L McNees; Jeff A Mahr; David Ornelles; Linda R Gooding
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Cellular and viral requirements for rapid endocytic entry of herpes simplex virus.

Authors:  Anthony V Nicola; Stephen E Straus
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection.

Authors:  Sayan Chakraborty; Mohanan Valiya Veettil; Virginie Bottero; Bala Chandran
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

5.  The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus.

Authors:  Alexander S Hahn; Johanna K Kaufmann; Effi Wies; Elisabeth Naschberger; Julia Panteleev-Ivlev; Katharina Schmidt; Angela Holzer; Martin Schmidt; Jin Chen; Simone König; Armin Ensser; Jinjong Myoung; Norbert H Brockmeyer; Michael Stürzl; Bernhard Fleckenstein; Frank Neipel
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

6.  Usage of heparan sulfate, integrins, and FAK in HPV16 infection.

Authors:  Cynthia Y Abban; Patricio I Meneses
Journal:  Virology       Date:  2010-05-02       Impact factor: 3.616

7.  Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1.

Authors:  Ossie F Dyson; Christopher M Traylen; Shaw M Akula
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

Review 8.  Viral activation of stress-regulated Rho-GTPase signaling pathway disrupts sites of mRNA degradation to influence cellular gene expression.

Authors:  Jennifer A Corcoran; Craig McCormick
Journal:  Small GTPases       Date:  2015-10-19

9.  Envelope glycoprotein gB of Kaposi's sarcoma-associated herpesvirus is essential for egress from infected cells.

Authors:  Harinivas H Krishnan; Neelam Sharma-Walia; Ling Zeng; Shou-Jiang Gao; Bala Chandran
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Role of protein kinase C delta in reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Einat Deutsch; Adina Cohen; Gila Kazimirsky; Sara Dovrat; Hadara Rubinfeld; Chaya Brodie; Ronit Sarid
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.